Pearl River Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,772
Closed -$205K 492
2022
Q1
$205K Buy
+2,772
New +$193K 0.06% 366
2021
Q2
Sell
-4,030
Closed -$249K 474
2021
Q1
$249K Buy
+4,030
New +$255K 0.08% 331
2020
Q1
Sell
-4,847
Closed -$285K 589
2019
Q4
$285K Buy
+4,847
New +$263K 0.11% 357
2019
Q3
Sell
-400
Closed -$17K 458
2019
Q2
$17K Buy
+400
New +$17.4K 0.11% 194

Other funds holding GMED

Pearl River Capital's GMED Position: Q2 2022 in Review

Pearl River Capital sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 2,772 shares — an estimated $205K sold.

Pearl River Capital first reported a position in GMED in Q2 2019 and held it in 4 quarters. The position peaked at $285K in Q4 2019. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Pearl River Capital reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Pearl River Capital sold 2,772 Globus Medical shares in Q2 2022, an estimated $205K.
  • Pearl River Capital first reported a position in Globus Medical in Q2 2019 and held it in 4 quarters.
  • Pearl River Capital's Globus Medical position peaked at $285K in Q4 2019.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Pearl River Capital's 13F filing for Q2 2022, filed 12 Aug 2022.